NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
March 02, 2023 08:30 ET
|
NEXGEL, INC.
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain LANGHORNE, Pa., March 02, 2023 (GLOBE...
NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds
December 08, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Reports Third Quarter 2022 Financial Results
November 08, 2022 16:11 ET
|
NEXGEL, INC.
Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26% LANGHORNE, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ:...
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
November 02, 2022 09:00 ET
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...
NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment
October 25, 2022 08:00 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL Develops New Hydrogel Patch to Treat Amblyopia
October 20, 2022 08:00 ET
|
NEXGEL, INC.
Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion by 2027 LANGHORNE, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- NEXGEL,...
NEXGEL to Participate in Upcoming Investor Conferences in October 2022
October 04, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
SAGE Journals Publishes New Data Revealing NEXGEL’s SilverSeal Hydrogel Dressing Improves Postsurgical Scarring
October 03, 2022 07:30 ET
|
NEXGEL, INC.
Patients Treated with SilverSeal Experienced Significantly Less Scarring and Improved Skin Functionality Following Surgical Incision LANGHORNE, Pa., Oct. 03, 2022 (GLOBE NEWSWIRE) -- NEXGEL,...
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
September 29, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...
NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022
September 07, 2022 07:30 ET
|
NEXGEL, INC.
LANGHORNE, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for...